Is there a shift in use of subacute rehabilitation (SAR) instead of hospice referral since immunotherapy became available

11530Background: Immunotherapy has rapidly become mainstream treatment. Since the first drug approval in 2011, we have noted a decline in referrals from inpatient oncology to hospice, and an increa...